The STEP-1 trial demonstrated mean weight loss of 14.9% with semaglutide over 68 weeks, while the SURMOUNT-1 trial showed tirzepatide achieving 16-22.5% weight reduction over 72 weeks
Typically, patients undergo multiple sessions , and their progress depends on various factors such as the area treated , lifestyle habits , and individual metabolic response
(15) Studies show us that dairy is a better source of B12 than fish, poultry, and meat
Brain exosomes as minuscule information hub for autism spectrum disorder
It is a common vitamin deficiency and is the most common cause of megaloblastic anemia in the United States
What Alpha Arbutin Does for Your Skin Targets specific areas of hyperpigmentation rather than brightening uniformly